Insurance companies are increasingly restricting coverage for GLP-1 medications, impacting patient access and affordability.

The collaboration will fund early-stage clinical development of SB-4826, CIT’s first-in-class SUMO E1 inhibitor, for patients ...

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...

Attorney General Paxton argues that the company’s programs and offerings were essentially bribes and resulted in millions in ...

Monica Seles partners with argenx to raise awareness for Myasthenia Gravis, sharing her journey to empower and support those affected by the condition.

SamaCare announced that it is officially ranked on Inc. ’s annual 5,000 list. 1 The cloud-based patient access platform for ...